Informations générales (source: ClinicalTrials.gov)
Prevalence of Endolymphatic Hydrops in Patients With a History of Congenital Cytomegalovirus Infection With Symptomatic Cochleo-vestibular Involvement (HYDROPS-CMV)
Observational
Fondation Ophtalmologique Adolphe de Rothschild (Voir sur ClinicalTrials)
décembre 2022
septembre 2025
29 juin 2024
The management of patients with a history of congenital CMV infection (whether
symptomatic or asymptomatic at birth) is modeled on their usual management.
Etablissements
Les établissements d'Île-de-France ayant mis à jour leurs données Origine et niveau de fiabilité des données | |||||
---|---|---|---|---|---|
HOPITAL FONDATION A. DE ROTHSCHILD | Guillaume POILLON | 21/06/2024 13:34:17 | Contacter | ||
Les établissements d'Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
AP-HP - Hôpital Robert Debré | Monique ELMALEH-BERGES | Contact (sur clinicalTrials) |
Critères
Tous
Inclusion Criteria:
- Patient over 6 months old
- With a history of confirmed congenital CMV infection
- Suffering from symptomatic cochleo-vestibular dysfunction (average hearing
threshold> 20dB in at least one ear and / or abnormal functioning of one or more
sectors at the vestibular level)
- For adult patients, having received informed information about the study and having
signed a consent to participate in the study
- For minor patients written consent of the two holders of the exercise of parental
authority
- Affiliate or beneficiary of a social security scheme
- Patient over 6 months old
- With a history of confirmed congenital CMV infection
- Suffering from symptomatic cochleo-vestibular dysfunction (average hearing
threshold> 20dB in at least one ear and / or abnormal functioning of one or more
sectors at the vestibular level)
- For adult patients, having received informed information about the study and having
signed a consent to participate in the study
- For minor patients written consent of the two holders of the exercise of parental
authority
- Affiliate or beneficiary of a social security scheme
- Patient benefiting from a legal protection measure
- Pregnant or breastfeeding woman
- Contraindication to MRI (implanted electrical device, metallic foreign body,
claustrophobia)
- Patient with a proven allergy to gadolinium
- Injection of gadolinium in the previous 7 days
- Known impairment of renal function ((estimated GFR <60 mL / min / 1.73 m²)